×
개인정보 취급방침
개인정보 처리방침에 대한 내용을 입력하십시오.
×
이용약관
서비스 이용약관에 대한 내용을 입력하십시오.
Company
비전과 미션
비즈니스 Area
리더십
함께하는 사람들
연혁
Technology
Nexavant®
PeptoVac®
Anti-cancer therapy with PD1 antibody
PulmonoVac®
Tissue and organ regeneration
PeptoC
Pipeline
Pipeline
Product
News & Event
News
Event
Recruit
인재상
복리후생
채용공고
Contact
Contact
Company
비전과 미션
비즈니스 Area
리더십
함께하는 사람들
연혁
Technology
Nexavant®
PeptoVac®
Anti-cancer therapy with PD1 antibody
PulmonoVac®
Tissue and organ regeneration
PeptoC
Pipeline
Pipeline
Product
News & Event
News
Event
Recruit
인재상
복리후생
채용공고
Contact
Contact
ENG
Technology
Technology
Company
Business
Pipeline
News & Event
Recruit
Contact
PeptoC
Nexavant®
PeptoVac®
Anti-cancer therapy with PD1 antibody
PulmonoVac®
Tissue and organ regeneration
PeptoC
Peptide complex drug development
A peptide complex formation technology without any chemical conjugation
Appropriated for
1
Better bioavailability
2
Improved efficacy
3
Can be used for the peptide application of
A receptor antagonist
Anti-cancer peptide for improved efficacy
Anti-microorganism peptide